These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2436547)

  • 1. [Pharmacokinetics and efficacy of delayed-action hydroquinidine in patients with ventricular extrasystole].
    Victor J; Turcant A; Tadei A; Allain P
    Ann Cardiol Angeiol (Paris); 1987 Mar; 36(3):163-6. PubMed ID: 2436547
    [No Abstract]   [Full Text] [Related]  

  • 2. [Activity of a new long-acting anti-arrhythmic drug on ventricular extrasystole. Study with Holter continuous electrocardiographic monitoring].
    Romano S; Pozzoni L; Verzoni A; Lomuscio A; Guffanti E; Croce L
    G Ital Cardiol; 1981; 11(5):657-62. PubMed ID: 6169582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of delayed-action preparations of mexiletine and dihydroquinidine in the treatment of ventricular extrasystolic arrhythmia].
    Accettura D; De Toma L; Mangini SG; Lagioia R; Scrutinio D; Mastropasqua F; Caiati C; Rizzon P
    Cardiologia; 1987 Sep; 32(9):999-1003. PubMed ID: 2446764
    [No Abstract]   [Full Text] [Related]  

  • 4. [Human pharmacokinetic study of a sustained-release preparation of hydroquinidine: single and chronic administration].
    Flouvat B; Delhotal B; Kahn JC; Crouzette J; Dubourg O; Roux A; Fodor F; Bourdarias JP
    Therapie; 1984; 39(4):337-44. PubMed ID: 6484877
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative study of a slow-release quinidine preparation and flecainide administered in 2 daily doses for the treatment of extrasystole].
    Clémenty J; Castagne D; Dallocchio M; Bricaud H
    Ann Cardiol Angeiol (Paris); 1984 Oct; 33(6):401-5. PubMed ID: 6208841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of the efficacy of 2 delayed-action preparations of hydroquinidine and quinidine in the prevention of pacing induced ventricular tachycardia].
    Lévy S; Moyal C; Dolla E; Cointe R; Bru P; Lauribe P; Paganelli F; Chanu P; Gérard R
    Arch Mal Coeur Vaiss; 1993 Sep; 86(9):1359-63. PubMed ID: 8129554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dihydroquinidine metabolites after the administration in man of a delayed-action preparation].
    Flouvat B; Resplandy G; Roux A; Friocourt P; Viel C; Plat M
    Therapie; 1988; 43(4):255-61. PubMed ID: 3187925
    [No Abstract]   [Full Text] [Related]  

  • 8. Ventricular ectopy.
    Grauer K; Lopez LM; Curry RW; Kravitz L; Robinson JD; Sands CR
    J Fam Pract; 1984 Dec; 19(6):731-3, 737, 741-2 passim. PubMed ID: 6209358
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative clinical evaluation of two salts of quinidine using 24-hour Holter monitor recordings.
    Thompson EJ; Marwaha R; Naik G
    Angiology; 1978 Mar; 29(3):251-9. PubMed ID: 77140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of a long-acting hydroquinidine preparation].
    Guffanti E; Vaccarella A; Meregalli M
    Minerva Cardioangiol; 1982; 30(7-8):381-5. PubMed ID: 7133428
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative study of quinidine and disopyramide in the treatment of stable ventricular extrasystole].
    Barnay C; Medvedowsky JL; Clémenty J; Bricaud H; Pellet J; Denis B; Machecourt J; Wolf JE; Dimitrio R; Egre A
    Arch Mal Coeur Vaiss; 1983 Aug; 76(8):909-17. PubMed ID: 6194768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of quinidine in humans after intravenous, intramuscular and oral administration.
    Greenblatt DJ; Pfeifer HJ; Ochs HR; Franke K; MacLaughlin DS; Smith TW; Koch-Weser J
    J Pharmacol Exp Ther; 1977 Aug; 202(2):365-78. PubMed ID: 577934
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of food on the comparative bioavailability of a fast- and slow-release dosage form of quinidine gluconate.
    Spénard J; Sirois G; Gagnon MA
    Int J Clin Pharmacol Ther Toxicol; 1983 Jan; 21(1):1-9. PubMed ID: 6832862
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cordichin in the treatment of ventricular extrasystole and tachycardial rhythm disorders].
    Jancke T
    ZFA (Stuttgart); 1982 Mar; 58(8):488-92. PubMed ID: 6176082
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antiarrhythmic efficacy and tolerance of slow-release mexiletine in comparison with hydroquinidine retard].
    Fazio S; Villari B; Petitto M; Santomauro M; Iacono C; Celentano A; de Divitiis O
    Minerva Cardioangiol; 1987 Nov; 35(11):631-6. PubMed ID: 3444537
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effectiveness of a combination of mexitil with etmozin, allapinin or quinidine in ventricular extrasystole].
    Abdalla A; Mazur NA
    Klin Med (Mosk); 1988 May; 66(5):57-60. PubMed ID: 2458502
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison of mexiletine and dihydroquinidine in the treatment of ventricular asystolic arrhythmia].
    Accettura D; De Toma L; Lagioia R; Mastropasqua F; Mangini SG; Scrutinio D; Rizzon P
    Cardiologia; 1985 Feb; 30(2):107-12. PubMed ID: 2415255
    [No Abstract]   [Full Text] [Related]  

  • 18. Propafenone versus quinidine slow-release for the treatment of chronic ventricular arrhythmias.
    Nielsen H; Sørum C; Rasmussen V; Madsen JK; Hansen JF
    Acta Cardiol; 1990; 45(5):359-63. PubMed ID: 1704168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clearance of quinidine during peritoneal dialysis.
    Hall K; Meatherall B; Krahn J; Penner B; Rabson JL
    Am Heart J; 1982 Sep; 104(3):646-7. PubMed ID: 6180621
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of chronic ventricular extrasystole].
    Seipel L; Breithardt G
    Dtsch Med Wochenschr; 1979 Aug; 104(31):1092-4. PubMed ID: 88320
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.